Literature DB >> 6991321

Mode of action of clonidine upon islet function: dissociated effects upon the time course and magnitude of insulin release.

V Leclercq-Meyer, A Herchuelz, I Valverde, E Couturier, J Marchand, W J Malaisse.   

Abstract

Clonidine (0.08 to 80.0 ng/ml) caused a dose-related inhibition of glucose-stimulated insulin release, but failed to affect glucose oxidation, glucose-stimulated 45Ca net uptake, and adenylate cyclase activity in isolated rat islets. Phentolamine antagonized the effect of clonidine upon insulin release. Despite profound inhibition of insulin secretion, the drug failed to affect the time course for the changes evoked by glucose in either 45Ca fractional outflow rate from perfused islets or insulin release from the isolated perfused pancreas. The latter changes were multiphasic, revealing an initial secretory peak, a period of low secretory activity, and a second secretory elevation before establishing a period characterized by a steadily and slowly increasing insulin output. In the clonidine-treated islets, the secretory rate was not significantly different from the basal value during the period after the initial secretory response. Thus, despite continuous stimulation with glucose, insulin release appears as a discontinuous phenomenon, even when little insulin is secreted during the initial phase of stimulation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991321     DOI: 10.2337/diab.29.3.193

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Dual action of clonidine on insulin release: suppression, but stimulation when alpha 2-adrenoceptors are blocked.

Authors:  A Schulz; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

Review 2.  Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications.

Authors:  P J Lefèbvre; G Paolisso; A J Scheen; J C Henquin
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

3.  Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release.

Authors:  A Schulz; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

4.  Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.

Authors:  T D Plant; J C Jonas; J C Henquin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 5.  The role of cyclic AMP in insulin release.

Authors:  W J Malaisse; F Malaisse-Lagae
Journal:  Experientia       Date:  1984-10-15

6.  Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics.

Authors:  S Ferlito; G Indelicato; S Di Vincenzo; F Del Campo; A La Vignera; C Fichera
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

Review 7.  THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.

Authors:  Anna Grodzinsky; Suzanne V Arnold; Dany Jacob; Boris Draznin; Mikhail Kosiborod
Journal:  Endocr Pract       Date:  2016-12-14       Impact factor: 3.443

8.  Mathematical modelling of stimulus-secretion coupling in the pancreatic B-cell. I. Dynamics of insulin release.

Authors:  Y Scholler; V De Maertelaer; W J Malaisse
Journal:  Acta Diabetol Lat       Date:  1983 Oct-Dec

9.  Dihydroergotamine, but not naloxone, counteracts lithium as an inhibitor of glucose-induced insulin release in isolated rat islets in vitro.

Authors:  T Fontela; O Garcia Hermida; J Gómez-Acebo
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

10.  Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets.

Authors:  J Langer; U Panten; S Zielmann
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.